Core Insights - The article discusses the recent signing of key projects at the Changzhou Zhonglou Synthetic Biology AI Research Institute, focusing on addressing industry pain points and public health needs through innovative collaborations in synthetic biology and AI [2][4]. Project Progress - The signing ceremony highlighted 11 cutting-edge projects aimed at enhancing the high-quality development of the synthetic biology AI industry, covering platform cooperation, innovation incubation, and smart healthcare [2][4]. - Five platform cooperation projects were initiated to address industry capability gaps, including an "AI + Industry Integration Platform" by iFlytek and a focus on AI-enabled cell therapy for solid tumors by the Changzhou Xitaihu Cell Therapy Research Institute [4]. - Three innovation incubation projects aim to transition research outcomes into industry applications, such as the AI synthetic biology computing platform to reduce anti-tumor drug development costs [4]. Smart Healthcare Initiatives - Three smart healthcare projects were launched to tackle public health issues, including a synthetic biology functional food project and an AI smart rehabilitation therapy project [4]. - The initiatives aim to shift healthcare services from reactive treatment to proactive prevention, enhancing overall health management [4]. Expert Insights - Following the signing ceremony, experts discussed trends in "Biological Intelligent Manufacturing" and the intersection of artificial intelligence with synthetic biology, providing case studies to illustrate these developments [5].